Neorabio delivers comprehensive multi-omics analysis and integration services to help partners understand disease mechanisms, identify novel targets, and map complex biological networks.
Neorabio delivers comprehensive multi-omics analysis and integration services to help partners understand disease mechanisms, identify novel targets, and map complex biological networks.
By combining AI-based target prediction, molecular docking, and large-scale virtual screening, Neorabio provides efficient and reliable in silico solutions for pharmaceutical R&D.
Our Synthetic Biology Platform connects digital design with experimental realization. We focus on gene editing, protein expression, and small-molecule and peptide synthesis to turn virtual constructs into tangible biological entities.
Built on our Synthetic Biology Platform, Neorabio's Product Ecosystem transforms innovation into standardized, scalable research products—enabling reproducible biology at scale.







